Michele Rhee
Vice President - Patient Experience, Patient Advocacy & Early Access Savara Pharmaceuticals
Michele Rhee is Vice President of Patient Experience, Patient Advocacy & Early Access at Savara, bringing more than 20 years of experience across patient engagement, clinical trial recruitment, drug development and early access. She leads Savara’s Patient Advocacy and Early Access Programs and has built and led patient-focused functions across multiple life sciences organisations. Her experience spans rare disease and oncology, with a particular focus on ensuring patient perspectives inform drug development, access strategies and decision-making throughout the product lifecycle.
Seminars
Thursday 25th March 2027
Strengthening Informed Consent, Physician Accountability & Shared Decision-Making
12:15 pm
- Improving how risks, uncertainties and limitations are communicated to patients
- Defining physician responsibilities throughout the patient access journey
- Managing difficult conversations around program closure and treatment discontinuation
- Strengthening trust through better informed consent and stakeholder engagement
